Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1945 1
1946 21
1947 12
1948 13
1949 6
1950 11
1951 19
1952 14
1953 18
1954 15
1955 10
1956 19
1957 25
1958 20
1959 23
1960 25
1961 33
1962 28
1963 37
1964 34
1965 39
1966 32
1967 42
1968 75
1969 124
1970 191
1971 482
1972 783
1973 849
1974 907
1975 984
1976 899
1977 841
1978 652
1979 620
1980 672
1981 567
1982 544
1983 570
1984 675
1985 652
1986 625
1987 605
1988 727
1989 813
1990 824
1991 852
1992 850
1993 886
1994 861
1995 883
1996 909
1997 870
1998 688
1999 701
2000 745
2001 673
2002 662
2003 625
2004 675
2005 613
2006 618
2007 596
2008 637
2009 667
2010 716
2011 774
2012 765
2013 950
2014 949
2015 1004
2016 1008
2017 1077
2018 1086
2019 1172
2020 1673
2021 1703
2022 1470
2023 1108
2024 466

Text availability

Article attribute

Article type

Publication date

Search Results

42,560 results

Results by year

Filters applied: . Clear all
Page 1
Remdesivir.
Bakheit AH, Darwish H, Darwish IA, Al-Ghusn AI. Bakheit AH, et al. Profiles Drug Subst Excip Relat Methodol. 2023;48:71-108. doi: 10.1016/bs.podrm.2022.11.003. Epub 2023 Feb 9. Profiles Drug Subst Excip Relat Methodol. 2023. PMID: 37061276 Free PMC article. Review.
Remdesivir is a prodrug designed to facilitate the intracellular transport of GS-441524 monophosphate and its subsequent biotransformation into GS-441524 triphosphate, a ribonucleotide analogue inhibitor of viral RNA polymerase. ...
Remdesivir is a prodrug designed to facilitate the intracellular transport of GS-441524 monophosphate and its subsequent biotransform …
Remdesivir: Quo vadis?
De Clercq E. De Clercq E. Biochem Pharmacol. 2021 Nov;193:114800. doi: 10.1016/j.bcp.2021.114800. Epub 2021 Oct 19. Biochem Pharmacol. 2021. PMID: 34678228 Free PMC article. Review.
Its key structural features are the fact that it is a C-nucleoside (adenosine) analogue, contains a 1'-cyano function, and could be considered as a ProTide based on the presence of a phosphoramidate group. ...
Its key structural features are the fact that it is a C-nucleoside (adenosine) analogue, contains a 1'-cyano function, and could be c …
An effective drug against COVID-19: reality or dream?
Yaghoubi A, Amel Jamehdar S, Movaqar A, Milani N, Soleimanpour S. Yaghoubi A, et al. Expert Rev Respir Med. 2021 Apr;15(4):505-518. doi: 10.1080/17476348.2021.1854092. Epub 2020 Dec 6. Expert Rev Respir Med. 2021. PMID: 33215942 Review.
Remdesivir: a pendulum in a pandemic.
Schwartz IS, Heil EL, McCreary EK. Schwartz IS, et al. BMJ. 2020 Nov 24;371:m4560. doi: 10.1136/bmj.m4560. BMJ. 2020. PMID: 33234523 No abstract available.
Repurposing drugs for the management of COVID-19.
Cusinato J, Cau Y, Calvani AM, Mori M. Cusinato J, et al. Expert Opin Ther Pat. 2021 Apr;31(4):295-307. doi: 10.1080/13543776.2021.1861248. Epub 2020 Dec 31. Expert Opin Ther Pat. 2021. PMID: 33283567 Review.
Cangrelor in clinical use.
Feng KY, Mahaffey KW. Feng KY, et al. Future Cardiol. 2020 Mar;16(2):89-102. doi: 10.2217/fca-2019-0095. Epub 2020 Feb 18. Future Cardiol. 2020. PMID: 32067479 Review.
Remdesivir: From Ebola to COVID-19.
Santoro MG, Carafoli E. Santoro MG, et al. Biochem Biophys Res Commun. 2021 Jan 29;538:145-150. doi: 10.1016/j.bbrc.2020.11.043. Epub 2020 Nov 19. Biochem Biophys Res Commun. 2021. PMID: 33388129 Free PMC article. Review.
Cangrelor AstraZeneca.
Chattaraj SC. Chattaraj SC. Curr Opin Investig Drugs. 2001 Feb;2(2):250-5. Curr Opin Investig Drugs. 2001. PMID: 11816839 Review.
Remdesivir-COVID-19: drug interactions in dentistry.
Gómez-Moreno G. Gómez-Moreno G. Eur Rev Med Pharmacol Sci. 2020 Sep;24(18):9739-9743. doi: 10.26355/eurrev_202009_23065. Eur Rev Med Pharmacol Sci. 2020. PMID: 33015819 Free article. Review.
42,560 results
You have reached the last available page of results. Please see the User Guide for more information.